← FDA Drug Approvals (Drugs@FDA)

ELIQUIS

NDA · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2012-12-28

Drug application

FDA Application #

NDA202155

Application type

New Drug Application

Brand name

ELIQUIS

Generic name

Apixaban

Active ingredients

APIXABAN

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL MYERS SQUIBB

First approval

2012-12-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown